This failure may have been related to the underlying biology of HER2-positive GC as previous studies have shown heterogeneous HER2 IHC staining patterns and lower HER2 expression in GC compared to those in breast cancer [87,88]. The gene discussed is ERBB2; the disease is breast cancer.